Abstract CT047: Interim results from the phase 1/2 ABILITY-1 study of a long-acting ‘beta-enhanced not-alpha’ IL-2 superkine in patients with advanced solid tumors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Victoria G. Atkinson, Warren Brenner, Jacqueline T. Brown, Luis Cabezón-Gutiérrez, Pablo Gajate, Seung T. Kim, Jenny Lee, Charlotte Lemech, Kim A. Margolin, Irene Moreno, Victor Moreno, Do-Youn Oh, Isabella Glitza Oliva, John J. Park, Hong Shue, Przemyslaw Twardowski, Ira Winer, Michael J. Chisamore, Amy Prawira, Fahar Merchant, Melissa Coello, Minh D. To, Rosemina Merchant, Arash Yavari, Paolo A. Ascierto
Institutions: Greenslopes Private Hospital, Emory University, Hospital Universitario de Torrejón, Hospital Universitario Ramón y Cajal, Samsung Medical Center, Chris O’Brien Lifehouse, Saint John's Health Center, Hospital Universitario Fundación Jiménez Díaz, Seoul National University Hospital, The University of Texas MD Anderson Cancer Center, Macquarie University, University of the Sunshine Coast, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Merck & Co., Inc., Rahway, NJ, USA (United States), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822344